AC
Aristides Capital’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.6M | Buy |
+28,467
| New | +$3.6M | 0.72% | 18 |
|
2024
Q3 | – | Sell |
-66,880
| Closed | -$9.18M | – | 265 |
|
2024
Q2 | $9.18M | Buy |
+66,880
| New | +$9.18M | 2.59% | 2 |
|
2023
Q3 | – | Sell |
-63,773
| Closed | -$8.1M | – | 182 |
|
2023
Q2 | $8.1M | Buy |
+63,773
| New | +$8.1M | 3.29% | 2 |
|
2022
Q3 | – | Sell |
-20,815
| Closed | -$2.45M | – | 158 |
|
2022
Q2 | $2.45M | Buy |
20,815
+7,515
| +57% | +$884K | 1.68% | 12 |
|
2022
Q1 | $1.73M | Sell |
13,300
-5,500
| -29% | -$717K | 1.06% | 17 |
|
2021
Q4 | $2.87M | Buy |
18,800
+7,000
| +59% | +$1.07M | 1.31% | 12 |
|
2021
Q3 | $1.91M | Sell |
11,800
-36,750
| -76% | -$5.94M | 0.7% | 18 |
|
2021
Q2 | $7.95M | Buy |
48,550
+44,150
| +1,003% | +$7.22M | 1.87% | 1 |
|
2021
Q1 | $662K | Buy |
+4,400
| New | +$662K | 0.27% | 43 |
|
2020
Q4 | – | Sell |
-6,020
| Closed | -$815K | – | 148 |
|
2020
Q3 | $815K | Sell |
6,020
-36,356
| -86% | -$4.92M | 0.57% | 26 |
|
2020
Q2 | $5.79M | Buy |
+42,376
| New | +$5.79M | 4.37% | 2 |
|